|Bid||217.76 x 800|
|Ask||217.82 x 800|
|Day's range||215.87 - 218.56|
|52-week range||210.28 - 276.69|
|Beta (5Y monthly)||0.67|
|PE ratio (TTM)||22.07|
|Earnings date||26 Oct 2021 - 01 Nov 2021|
|Forward dividend & yield||7.04 (3.24%)|
|Ex-dividend date||16 Aug 2021|
|1y target est||250.00|
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
New data from the phase 3 trial of tezepelumab bodes well for the drug candidate becoming a significant revenue producer in the near future.
Everyone likes a bargain, and buying stocks "on sale" is particularly alluring when the companies hitting a rough patch have familiar names, such as those in the Dow Jones Industrial Average. The index is up by about 16%, but the three laggards' stock performance is in negative territory. With that caveat in mind, it's time to examine this year's worst-performing companies in the Dow Jones Industrial Average to see if these are value stocks or if their troubles have only begun.